(Q44063957)

English

Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

J Sugita

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

T Matsushita

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

H Kashiwazaki

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Kosugi

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

S Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

K Wakasa

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

S Shiratori

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Ibata

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Y Shono

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

A Shigematsu

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Obara

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

K Fujimoto

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

T Endo

13

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Nishio

14

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

T Kondo

15

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

S Hashino

16

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

J Tanaka

17

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Asaka

18

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M Imamura

19

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

21 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

258-264

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

In vivo binding of [3H]nimodipine in rat brain after transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Folinic acid administration following MTX as prophylaxis for GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Methotrexate and Citrovorum Factor after Histoincompatible Allogeneic Bone Marrow Transplants in Dogs

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Severe renal toxicity due to intermediate-dose methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

21 January 2018

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.53

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2011.53

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44063957&oldid=2206416755"